“Ebola In The United States”. J Allergy Clin Immunol 135. J Allergy Clin Immunol: 868-871. http://www.ncbi.nlm.nih.gov/pubmed/25533525.
. 2015. “Sublingual Immunotherapy For Peanut Allergy: Long-Term Follow-Up Of A Randomized Multicenter Trial”. J Allergy Clin Immunol. J Allergy Clin Immunol. http://www.ncbi.nlm.nih.gov/pubmed/25656999.
. 2015. “Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (Accent): Design And Implementation Of A Multi-Site, Randomized Controlled Study In The National Institute On Drug Abuse Clinical Trials Network”. Contemp Clin Trials 39. Contemp Clin Trials: 211-223. http://www.ncbi.nlm.nih.gov/pubmed/25179587.
. 2014. “Brief Intervention For Patients With Problematic Drug Use Presenting In Emergency Departments: A Randomized Clinical Trial”. Jama Intern Med 174. Jama Intern Med: 1736-1745. http://www.ncbi.nlm.nih.gov/pubmed/25179753.
. 2014. . 2014.
. 2014.
“Patient Registries For Substance Use Disorders”. Subst Abuse Rehabil 5. Subst Abuse Rehabil: 81-86. http://www.ncbi.nlm.nih.gov/pubmed/25114612.
. 2014. “Cocaine Use Reduction With Buprenorphine (Curb): Rationale, Design, And Methodology”. Contemp Clin Trials 34. Contemp Clin Trials: 196-204. http://www.ncbi.nlm.nih.gov/pubmed/23159524.
. 2013. . 2013.
“Induction Onto Extended-Release Naltrexone In 302 Cocaine-Dependent Opioid Users”. In College On Problems Of Drug Dependence Meeting. College On Problems Of Drug Dependence Meeting. San Diego CA. http://www.cpdd.vcu.edu/index.html.
. 2013. . 2013.
“A Phase 1 Study Of Heat/phenol-Killed, E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara H 1, Ara H 2, And Ara H 3 (Emp-123) For The Treatment Of Peanut Allergy.”. Allergy 68 (6). Allergy: 803-8. doi:10.1111/all.12158.
. 2013. “Response To Commentaries”. Addiction 108. Addiction: 12-13. http://www.ncbi.nlm.nih.gov/pubmed/23279355.
. 2013. “Sublingual Immunotherapy For Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial”. J Allergy Clin Immunol 131. J Allergy Clin Immunol: 119-127.e1-7. http://www.ncbi.nlm.nih.gov/pubmed/23265698.
. 2013. “A Successful Support Program For Cell Therapy: An Update From The Production Assistance For Cellular Therapies (Pact) Group”. Transfusion 53. Transfusion: Supplement AP34. http://denverconvention.com/events/details/aabb-annual-meeting-and-txpo.
. 2013. “A Successful Web Seminar Program For Cell Therapy: An Update From The Production Assistance For Cellular Therapies (Pact) Group”. In Aabb Annual Meeting & Txpo, Denver, Co, No. 2S, 53:Supplement AP40. Aabb Annual Meeting & Txpo, Denver, Co. Denver, CO: Transfusion. https://www.aabb.org/Pages/Homepage.aspx.
. 2013. “Clinical Trial Management: Monitoring Progress, Sites And Safety; New Paradigms For Efficiency”. In 5Th Annual Clinical Research Management Workshop At The Yale Center For Clinical Investigation. 5Th Annual Clinical Research Management Workshop At The Yale Center For Clinical Investigation. New Haven, CT. http://ycci.yale.edu/news/crm2012.aspx.
. 2012. “Consortium Of Food Allergy Research (Cofar). Relationship Of Cytokine And Regulatory Gene Expression To The Outcomes Of Milk And Egg Allergy In An Atopic Cohort.”. In Aaaai - American Academy Of Allergy, Asthma & Immunology, 125:AB25. Aaaai - American Academy Of Allergy, Asthma & Immunology. Orlando, FL: Journal of Allergy and Clinical Immunology Vol. 129, Issue 2, Supplement, Page AB25. http://download.journals.elsevierhealth.com/pdfs/journals/0091-6749/PIIS0091674911029174.pdf.
. 2012. “Design Considerations For A Study To Evaluate The Impact Of Smoking Cessation Treatment On Stimulant Use Outcomes In Stimulant-Dependent Individuals”. Contemp Clin Trials 33. Contemp Clin Trials: 197-205. http://www.ncbi.nlm.nih.gov/pubmed/22005174.
. 2012. “Estimating Death Rates In Substance Use Disorder”. In The Society For Clinical Trials 33Rd Annual Meeting. The Society For Clinical Trials 33Rd Annual Meeting. Miami, FL. http://www.sctweb.org/public/meetings/2012/home.cfm.
. 2012. “Evaluation Of Buspirone For Relapse-Prevention In Adults With Cocaine Dependence: An Efficacy Trial Conducted In The Real World”. Contemp Clin Trials 33. Contemp Clin Trials: 993-1002. http://www.ncbi.nlm.nih.gov/pubmed/22613054.
. 2012. “Oral Immunotherapy For Treatment Of Egg Allergy In Children”. N Engl J Med 367. N Engl J Med: 233-243. http://www.ncbi.nlm.nih.gov/pubmed/22808958.
. 2012. “A Phase 1 Study Of Heat/phenol Killed, E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara H 1, Ara H 2, And Ara H 3 (Emp-123) For The Treatment Of Peanut Allergy”. In Aaaai - American Academy Of Allergy, Asthma & Immunology, 129(2):AB27. Aaaai - American Academy Of Allergy, Asthma & Immunology. Orlando, FL: Journal of Allergy and Clinical Immunology Vol. 129, Issue 2, Supplement, Page AB27. http://download.journals.elsevierhealth.com/pdfs/journals/0091-6749/PIIS0091674911027278.pdf.
. 2012. “Sublingual Immunotherapy For Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial”. In Aaaai - American Academy Of Allergy, Asthma & Immunology, 129(2):AB66. Aaaai - American Academy Of Allergy, Asthma & Immunology. http://annualmeeting.aaaai.org/virtual/.
. 2012. “Design Of Nida Ctn Protocol 0047: Screening, Motivational Assessment, Referral, And Treatment In Emergency Departments (Smart-Ed)”. Am J Drug Alcohol Abuse 37. Am J Drug Alcohol Abuse: 417-425. http://www.ncbi.nlm.nih.gov/pubmed/21854285.
. 2011.